World hepatitis day is observed on July 28 every year. World Hepatitis Day is an annual event that each year provides international focus for patient groups and people living with hepatitis B and C. It aims to raise global awareness of hepatitis B and hepatitis C and encourage prevention, diagnosis and treatment. If Hepatitis is left untreated and unmanaged, it can lead to liver cirrhosis and complications like liver cancer or liver failure.
World hepatitis day has been led by the world hepatitis alliance since 2007 and on May 2010, it got global endorsement from the World Health Organization (WHO). In 2010, July 28 was designated as the WORLD HEPATITIS DAY in order to provide opportunity for education, and greater understanding of viral hepatitis as a global public health problem, and to stimulate the strengthening of preventive and control measures of this disease. The reason July 28 was chosen was also to honor Nobel Laureate Prof. Blumberg who discovered hepatitis B virus as his birthday is on July 28.
The WHO estimates that over 180 million people worldwide are infected with hepatitis C virus (HCV) and a further 350-400 million people are chronically infected with the hepatitis B virus (HBV), a virus that is 100 times more infectious than HIV.
Chronic HBV and HCV can have serious consequences. It has led to liver cirrhosis in 20-25% and hepato-cellular carcinoma in 1-5% of cases. Cirrhosis is a consequence of chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue and regenerative nodules (lumps that occur as a result of a process in which damaged tissue is regenerated), leading to loss of liver function. Ascites is the most common complication of cirrhosis, and is associated with a poor quality of life, increased risk of infection, and a poor long-term outcome. Other potentially life-threatening complications are hepatic encephalopathy (confusion and coma) and bleeding from esophageal varices. Cirrhosis is generally irreversible, and treatment usually focuses on preventing progression and complications. In advanced stages of cirrhosis the only option is a liver transplant.
Acute HBV has a fatality rate of up to 2% in the elderly. These figures indicate the burden of both diseases. Treatment is available for both but is expensive and lengthy. A safe and cost-effective vaccine exists for HBV.
Kamalahar – an ayurvedic medicine provides cost-effective treatment of hepatitis without causing any side effects. It is composed of herbal ingredients which have been known to treat liver disorder over hundreds of years. The ingredients have been used by many people practicing traditional or alternative medicine to strengthen liver. It is the combination of those ingredients such as Tecoma undulata, Phyllanthus urinaria, Embelia ribes, Taraxacum officinale, Nyctanthes arbortritis and Terminalia arjuna which makes Kamalahar very effective for the treatment of hepatitis, cirrhosis, fatty liver, ascites, jaundice. This year Kamalahar expanded its reach on the World Hepatitis Day to reach out to more patients. The goal for Kamalahar is to reach all patients suffering from Hepatitis, Cirrhosis, Fatty Liver, ascites and other liver disorders. Kamalahar has already treated liver disorder for millions of people suffering from it in the eastern part of India. One great testimonial on treatment of ascites using Kamalahar is available on the website.